arrow
M

Massimo Broggini

istituto di ricerche farmacologiche mario negri irccs
H指数:53
被引数:9,676

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
2025-02-170
OAAI
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy

热量限制和二甲双胍选择性改善LKB1-mutated NSCLC肿瘤对化疗和化疗免疫治疗的反应

2024-01-027
OAAI
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
2023-06-017
PRE
Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies

来自同一患者的两个复发的两个新建立的胸腺瘤PDXs的隔离和表征: 研究胸腺恶性肿瘤的新工具

2022-12-141
OAAI
The integrated stress response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer
2021-07-3031
OAAI
Anti-Influenza Effect of Nanosilver in a Mouse Model
2020-11-1312
OAAI
Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy
2020-07-302
OAAI